Literature DB >> 6379686

Cellular and molecular effects of adriamycin on dividing and nondividing cells.

S C Barranco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6379686     DOI： 10.1016/0163-7258(84)90007-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  11 in total

1.  Inhibition of O6-alkylguanine-DNA alkyltransferase and DNase I activities in vitro by some alkylating substances and antineoplastic agents.

Authors:  A Link; K Tempel
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines.

Authors:  P B Jensen; H Roed; L Vindeløv; I J Christensen; H H Hansen
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

3.  Comparison of cancer chemotherapeutic agents in asynchronous and synchronous 9L cells.

Authors:  S D Henderson; B F Kimler; M L Barnes
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

Review 4.  Topoisomerase I in multiple drug resistance.

Authors:  A Pessina
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

5.  Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy.

Authors:  N Iliskovic; B B Hasinoff; K L Malisza; T Li; I Danelisen; P K Singal
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 6.  Clinical pharmacokinetics of doxorubicin.

Authors:  P A Speth; Q G van Hoesel; C Haanen
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

7.  Combination of flavone acetic acid (FAA) with adriamycin, cis-platinum and difluoromethylornithine (DFMO) in vitro against human colon cancer cells.

Authors:  S S Neelam; A Bernabei; C Freedland; R Thompson; T H Corbett; G D Luk
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

8.  Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity.

Authors:  P Skehan; J Thomas; S J Friedman
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

9.  A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model.

Authors:  Jessica E Pritchard; Patrick M Dillon; Mark R Conaway; Corinne M Silva; Sarah J Parsons
Journal:  Oncology       Date:  2012-09-05       Impact factor: 2.935

10.  Topoisomerase I inhibitors and drug resistance.

Authors:  R E Parchment; A Pessina
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.